Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas

FEBS Letters

Volumn 430, Issue 3, 1998, Pages 227-230

  Dzhandzhugazyan, Karine N ^a   Kirkin, Alexei F ^a   Thor Straten, Per ^a   Zeuthen, Jesper ^a  

^a Institute of Biology   (Denmark)

Author keywords

Adhesion; CD39; Differentiation marker; Ecto ATPase; Human melanoma; Immune escape mechanism

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE DIHYDROLASE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL ADHESION; HUMAN; HUMAN CELL; HYDROLYSIS; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADENOSINE TRIPHOSPHATASES; ANTIGENS, CD; APYRASE; CELL DIFFERENTIATION; CELL LINE; DISEASE PROGRESSION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032479195     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00603-6     Document Type: Article

References (25)

1. Rosenberg S.A. J. Natl. Cancer Inst. 88:1996;1635-1644.
2. Herst R.A., Weiss J., Ehnis A., Cavenee W.K., Arden K.C. Cancer Res. 54:1994;3111-3114.
3. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Cancer Res. 57:1997;3660-3663.
4. thor Straten P., Kirkin A.F., Seremet T., Zeuthen J. Int. J. Cancer. 70:1997;582-586.
5. Burnstock G. Drug Dev. Res. 28:1993;195-206.
6. Plesner L. Int. Rev. Cytol. 158:1995;141-214.
7. Kanzas G.S., Wood G.S., Tedder T.F. J. Immunol. 146:1991;2235-2244.
8. Wang T.F., Guidotti G. J. Biol. Chem. 271:1996;9898-9901.
9. Kirkin A.F., Peterson T.R., Olsen A.C., Li L., thor Straten P., Zeuthen J. Cancer Immunol. Immunother. 41:1995;71-81.
10. Kirkin A.F., thor Straten P., Zeuthen J. Cancer Immunol. Immunother. 42:1996;203-212.
11. Villalba J.M., Palmgren M.G., Berberian G., Ferguson C., Serrano R. J. Biol. Chem. 267:1992;12341-12349.
12. Baykov A.A., Evtushenko O.A., Avaeva S.M. Anal. Biochem. 171:1988;266-270.
13. Dzhandzhugazyan K., Bock E. Biochemistry. 36:1997;15381-15395.
14. Dzhandzhugazyan K.N., Modyanov N.N., Ovchinnikov Y.A. Bioorg. Khim. 7:1981;847-857.
15. Girolomoni G., Santantonio M.L., Pastore S., Bergstresser P.L., Giannetti A., Cruz P.D. Jr. J. Invest. Dermatol. 100:1993;282-287.
16. Kaczmarek E., Koziak K., Sevigny J., Siegel J.B., Anrather J., Beaudoin A.R., Bach F.H., Robson S.C. J. Biol. Chem. 271:1996;33116-33122.
17. Knowles A.F., Leis J.F., Kaplan N.O. Cancer Res. 41:1981;4031-4038.
18. Guidotti G. Chem. Biol. 3:1996;703-706.
19. Sugita M., Yue Y., Foskett J.K. EMBO J. 17:1998;898-908.
20. Filippini A., Taffs R.E., Sitkovsky M.V. Proc. Natl. Acad. Sci. USA. 87:1990;8267-8271.
21. Sud'ina G.F., Mirzoeva O.K., Galkina S.I., Pushkareva M.A., Ullrich V. FEBS Lett. 423:1998;243-248.
22. Gouttefangeas C., Mansur I., Schmid M., Dastot H., Gélin C., Mahouy G., Boumsell L., Bensussan A. Eur. J. Immunol. 22:1992;2681-2685.
23. Yamaguchi K., Ohnishi T. Histochemistry. 54:1977;191-199.
24. Karasaki S., Suh M.H., Salas M., Raymond J. Cancer Res. 40:1980;1318-1328.
25. Maliszewski C.R., Delespesse G.J.T., Schoenborn M.A., Armitage R.J., Fanslow W.C., Nakajima T., Baker E., Sutherland G.R., Poindexter K., Birks C., Alpert A., Friend D., Gimpel S.D., Gayle III R.B. J. Immunol. 153:1994;3574-3583.